A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : RRMM

Search Conditions:
Search Keyword : RRMM
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: RRMM
Appearance Frequency: 452 time(s)
Long forms: 16

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
refractory multiple myeloma
(177 times)
Neoplasms
(71 times)
PFS (33 times)
ORR (27 times)
OS (22 times)
2011 Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study.
relapsed/refractory multiple myeloma
(175 times)
Hematology
(73 times)
PFS (47 times)
ORR (32 times)
OS (31 times)
2011 How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinions.
relapsed/refractory MM
(44 times)
Hematology
(16 times)
MM (42 times)
NDMM (9 times)
PFS (9 times)
2011 Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma.
refractory MM
(25 times)
Neoplasms
(11 times)
MM (23 times)
PFS (8 times)
MoAb (3 times)
2012 Safety and efficacy of lenalidomide in relapsed or refractory multiple myeloma.
refractory/relapsed multiple myeloma
(10 times)
Hematology
(4 times)
PFS (4 times)
ORR (3 times)
OS (3 times)
2014 Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma.
refractory myeloma
(5 times)
Hematology
(2 times)
MM (3 times)
AKI (1 time)
CFZ (1 time)
2017 Combination therapy with monoclonal antibodies for treatment of newly diagnosed multiple myeloma.
refractory/relapsed MM
(3 times)
Neoplasms
(2 times)
MM (3 times)
VGPR (2 times)
AEs (1 time)
2016 Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy.
relapsed/refractory myeloma
(3 times)
Hematology
(2 times)
MM (2 times)
ASCT (1 time)
CAR-T (1 time)
2021 An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myeloma.
real-time respiratory motion management
(2 times)
Neoplasms
(2 times)
POP-ART RT (2 times)
2020 Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes.
10  relapsed-refractory multiple myeloma patients
(2 times)
Hematology
(2 times)
OS (2 times)
PFS (2 times)
2018 Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.
11  range resolved mode mixing
(1 time)
Ophthalmology
(1 time)
--- 2015 Range resolved mode mixing in a large volume for the mitigation of speckle and strategic target orientation requirements in active millimeter-wave imaging.
12  recording respirable mass monitor
(1 time)
Occupational Medicine
(1 time)
--- 1978 Laboratory evaluation of a recording respirable mass monitor.
13  recurrent and relapsed MM
(1 time)
Biochemistry
(1 time)
GEO (1 time)
MM (1 time)
NDMM (1 time)
2021 Proteomics-Based Approach Reveals the Involvement of SERPINB9 in Recurrent and Relapsed Multiple Myeloma.
14  recurrent refractory MM
(1 time)
Hematology
(1 time)
CR (1 time)
MM (1 time)
MRD (1 time)
2021 [The Significance of CD319 and CD269 in the Detection of Immunophenotyping and Minimal Residual Disease in Multiple Myeloma Patients].
15  Relapsing-remitting multiple sclerosis
(1 time)
Medicine
(1 time)
--- 2020 Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.
16  Relaxation Response and Mindfulness Meditation
(1 time)
Neoplasms
(1 time)
KY (1 time)
OCD (1 time)
RCT (1 time)
2005 Patient perspectives: Kundalini yoga meditation techniques for psycho-oncology and as potential therapies for cancer.